Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Fabio De Gregorio"'
Autor:
Beth L. Nordstrom, Bin Cai, Fabio De Gregorio, Lu Ban, Kathy H. Fraeman, Yuki Yoshida, Trevor Gibbs
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 13 (2022)
Introduction: The primary aim of this study was to compare the incidence of venous thromboembolism (VTE) among women initiating ospemifene vs other selective estrogen receptor modulator (SERM) therapies for estrogen-deficiency conditions or breast ca
Externí odkaz:
https://doaj.org/article/d05c71dc183f441cb55bc9e892a0ada9
Autor:
Marco Sardella, Glyn Belcher, Calin Lungu, Terenzio Ignoni, Manuela Camisa, Doris Irene Stenver, Paolo Porcelli, Margherita D’Antuono, Nicola Gian Castiglione, Anna Adams, Giovanni Furlan, Ilaria Grisoni, Sarah Hall, Laura Boga, Valentina Mancini, Mircea Ciuca, David Chonzi, Brian Edwards, Arduino A Mangoni, Marco Tuccori, Elena Prokofyeva, Fabio De Gregorio, Mario Bertazzoli Grabinski Broglio, Bert van Leeuwen, Paola Kruger, Christian Rausch, Hervé Le Louet
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Externí odkaz:
https://doaj.org/article/e2f577c0d23646f1bd9f7bce36bd7551
Autor:
Trevor Gibbs, Yuki Yoshida, Beth L. Nordstrom, Bin Cai, Fabio De Gregorio, Kathy H. Fraeman, Nafeesa Dhalwani
Publikováno v:
Menopause. 27:864-871
Objective Ospemifene is a nonsteroidal selective estrogen receptor modulator (SERM) for the treatment of moderate symptomatic vulvar and vaginal atrophy (VVA) due to menopause. A postauthorization safety study is currently examining the incidence of
Autor:
Fabio De Gregorio, Arduino A. Mangoni, Giovanni Furlan, Terenzio Ignoni, Marco Tuccori, Hervé Le Louet, Bert van Leeuwen, Nicola Gian Castiglione, Manuela Camisa, Marco Sardella, Anna L. Adams, Paolo Porcelli, Doris Irene Stenver, Glyn Belcher, Elena Prokofyeva, Valentina Mancini, Brian Edwards, Ilaria Grisoni, Mircea Ciuca, Mario Bertazzoli Grabinski Broglio, Margherita D'Antuono, David Chonzi, Laura Boga, Calin Lungu, Christian Rausch, Paola Kruger, Sarah Hall
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Autor:
Paolo Conti, Yassine Boukadida, Fabrizio Marignetti, G. Rubino, Fabio De Gregorio, Vincenzo Giovanni Longobardi, Espedito Iengo
This paper presents an experimental study of the vibration and the acoustic noise emitted by inverter-fed induction machines (IMs). The IM fits many applications, due to its cost efficiency and simple construction. Moreover, IMs are characterized by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe03af039e35e0c9a5832f9618b2aeb
https://hdl.handle.net/11573/1678409
https://hdl.handle.net/11573/1678409
Autor:
Simon Portsmouth, Luis Casanova, Eriko Ogura, Takuhiro Sonoyama, Fabio De Gregorio, Tsutae Den Nagata, Roger Echols, Yuko Matsunaga
Publikováno v:
Open Forum Infectious Diseases
Background Cefiderocol (CFDC), the first siderophore cephalosporin, is approved in the United States (complicated urinary tract infections [cUTI]) and Europe for the treatment of patients with Gram-negative (GN) infections with limited treatment opti
Publikováno v:
Maturitas. 124:162
Autor:
Roberto Sampaolesi, Maurizio Taloni, Paolo Brusini, Michele Virno, Silvio Di Staso, Jose Pecori Giraldi, Gaetano Stecchi, Fabio De Gregorio
PURPOSE The purpose of the study was to assess the effect of ibopamine (3,4 di-isobutyrrylester of N-methyldopamine), a D1-dopamine agonist, on intraocular pressure (IOP) in offspring of parents with primary openangle glaucoma as a consequence of out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9a7ab47abceeba40ca7056957527e9d
http://hdl.handle.net/11697/4993
http://hdl.handle.net/11697/4993
Publikováno v:
International Ophthalmology. 20:141-146
Background: Topically administered 2% ibopamine (a dopaminergic agonist) induces a transitory ocular hypertension in 92% of patients with primary open-angle glaucoma and in 52% of patients with normal tension glaucoma. In normal eyes, ibopamine has n
Publikováno v:
Acta Ophthalmologica Scandinavica. 77:13-15